Primary Peritoneal Carcinoma Active Not Recruiting Phase 1 Trials for Lenvatinib (DB09078)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02788708Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerTreatment